Alphageneron Announces Successful Completion of FDA Pre-IND Meeting of Proposed Phase II Clinical…
CAMBRIDGE, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a clinical stage pharmaceutical company with a robust product portfolio of autologous and allogeneic natural killer…